Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 13, Pages 3516
Publisher
Baishideng Publishing Group Inc.
Online
2016-03-28
DOI
10.3748/wjg.v22.i13.3516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
- (2015) R. Yaeger et al. CLINICAL CANCER RESEARCH
- Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
- (2015) Amanda I. Phipps et al. GASTROENTEROLOGY
- Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
- (2015) Frank A. Sinicrope et al. GASTROENTEROLOGY
- The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
- (2014) Christina Therkildsen et al. ACTA ONCOLOGICA
- Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
- (2014) Y. Y. Juo et al. ANNALS OF ONCOLOGY
- Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
- (2014) J. Y. Douillard et al. ANNALS OF ONCOLOGY
- B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
- (2014) R. Herr et al. CANCER RESEARCH
- RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy
- (2014) Virginia Alonso-Espinaco et al. EUROPEAN JOURNAL OF CANCER
- CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
- (2014) Stacey Shiovitz et al. GASTROENTEROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Associations of Anthropometric Factors with KRAS and BRAF Mutation Status of Primary Colorectal Cancer in Men and Women: A Cohort Study
- (2014) Jenny Brändstedt et al. PLoS One
- SOX2 Expression Is Regulated by BRAF and Contributes to Poor Patient Prognosis in Colorectal Cancer
- (2014) Ida V. Lundberg et al. PLoS One
- Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies
- (2014) Jeanne Tie et al. Targeted Oncology
- Claudin-1 Expression Is Elevated in Colorectal Cancer Precursor Lesions Harboring the BRAF V600E Mutation
- (2014) Maria Caruso et al. Translational Oncology
- MicroRNA-31 expression in colorectal serrated pathway progression
- (2014) Hironori Aoki WORLD JOURNAL OF GASTROENTEROLOGY
- Serrated pathway in colorectal carcinogenesis
- (2014) Letícia Yamane WORLD JOURNAL OF GASTROENTEROLOGY
- Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
- (2014) Fabio Coppedè WORLD JOURNAL OF GASTROENTEROLOGY
- Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
- (2013) Vlad Popovici et al. BMC CANCER
- Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
- (2013) Marisa Donada et al. BMC GASTROENTEROLOGY
- The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
- (2013) X Xing et al. BRITISH JOURNAL OF CANCER
- Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway
- (2013) K. Nosho et al. CARCINOGENESIS
- Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of BRAFV600E Colorectal Cancer
- (2013) E. M. Coffee et al. CLINICAL CANCER RESEARCH
- BRAFmutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis
- (2013) C. Clancy et al. Colorectal Disease
- Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency
- (2013) Heather Dawson et al. INTERNATIONAL JOURNAL OF CANCER
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
- (2013) Christophe Rosty et al. PLoS One
- The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis
- (2013) Zi-Xu Yuan et al. PLoS One
- Serrated pathway: Alternative route to colorectal cancer
- (2013) Árpád V Patai WORLD JOURNAL OF GASTROENTEROLOGY
- Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study
- (2013) Lars Henrik Jensen et al. CELLULAR ONCOLOGY
- Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
- (2013) Sakarias Wangefjord et al. Biology of Sex Differences
- Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF
- (2013) Alexandra Thiel et al. Frontiers in Oncology
- BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
- (2012) A. I. Phipps et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
- (2012) M. Mao et al. CLINICAL CANCER RESEARCH
- BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis
- (2012) Matthew F. Kalady et al. DISEASES OF THE COLON & RECTUM
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
- (2012) Carsten Bokemeyer et al. EUROPEAN JOURNAL OF CANCER
- Epigenetics of Colorectal Cancer
- (2012) Ajay Goel et al. GASTROENTEROLOGY
- A combined oncogenic pathway signature ofBRAF,KRASandPI3KCAmutation improves colorectal cancer classification and cetuximab treatment prediction
- (2012) Sun Tian et al. GUT
- Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
- (2012) Sae-Won Han et al. INTERNATIONAL JOURNAL OF CANCER
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Molecular Features of Colorectal Hyperplastic Polyps and Sessile Serrated Adenoma/Polyps From Korea
- (2011) Kyoung-Mee Kim et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
- (2011) Byung-Hoon Min et al. BMC CANCER
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
- (2011) H. Yang et al. CANCER RESEARCH
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video)
- (2011) Uma S. Tadepalli et al. GASTROINTESTINAL ENDOSCOPY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics and colorectal cancer
- (2011) Victoria Valinluck Lao et al. Nature Reviews Gastroenterology & Hepatology
- The Clinical Significance of Serrated Polyps
- (2010) Christopher S Huang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- DNA methylation predicts recurrence from resected stage III proximal colon cancer
- (2010) Joong Bae Ahn et al. CANCER
- Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab
- (2010) Jolien Tol et al. EUROPEAN JOURNAL OF CANCER
- The Chromosomal Instability Pathway in Colon Cancer
- (2010) Maria S. Pino et al. GASTROENTEROLOGY
- Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
- (2010) Barbara Leggett et al. GASTROENTEROLOGY
- 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
- (2010) Rodrigo Jover et al. GASTROENTEROLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
- (2010) Sun Lee et al. PATHOLOGY INTERNATIONAL
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
- (2009) F Loupakis et al. BRITISH JOURNAL OF CANCER
- The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum
- (2009) K. Wallace et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
- (2009) Hiromu Suzuki et al. CARCINOGENESIS
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps
- (2009) Dominique Sandmeier et al. HISTOPATHOLOGY
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma
- (2009) N J Carr et al. JOURNAL OF CLINICAL PATHOLOGY
- BRAFMutation in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer
- (2009) D L Worthley et al. ONCOGENE
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Distinct CpG island methylation profiles andBRAFmutation status in serrated and adenomatous colorectal polyps
- (2008) Yong Ho Kim et al. INTERNATIONAL JOURNAL OF CANCER
- LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
- (2008) Shuji Ogino et al. INTERNATIONAL JOURNAL OF CANCER
- Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?
- (2008) Barry Iacopetta et al. International Journal of Clinical Oncology
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Folylpolyglutamate synthase and γ-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity
- (2007) Etsuko Sakamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now